[E] CARRICK THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 CLINICAL TRIAL OF ITS ORAL CDK7 INHIBITOR: CT7001 Add to clipboard Item · 30/11/2017 Part of UoA 8 Press release for CT7001 Phase 1 trail Carrick therapeutics